Normal diffusion-weighted MR imaging predicts a good prognosis in extrapontine myelinolysis-induced parkinsonism.
Shin
Hae-Won
HW
Song
Dongbeom
D
Sohn
Young H
YH
D000328:Adult; D000437:Alcoholism / Q000150:complications*; D002421:Caudate Nucleus / Q000473:pathology; D038524:Diffusion Magnetic Resonance Imaging; D018450:Disease Progression; D005215:Fasting; D006801:Humans; D022124:Hyperammonemia / Q000209:etiology; D007010:Hyponatremia / Q000150:complications; D008108:Liver Diseases, Alcoholic / Q000097:blood / Q000150:complications / Q000473:pathology; D008297:Male; D017590:Myelinolysis, Central Pontine / Q000150:complications*; D009404:Nephrotic Syndrome / Q000150:complications / Q000188:drug therapy; D020734:Parkinsonian Disorders / Q000209:etiology / Q000473:pathology*; D011149:Pons / Q000473:pathology; D011239:Prednisolone / Q000627:therapeutic use; D011379:Prognosis; D011699:Putamen / Q000473:pathology
D011239:Prednisolone